These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 24628824)

  • 1. Improving family communication after a new genetic diagnosis: a randomised controlled trial of a genetic counselling intervention.
    Hodgson JM; Metcalfe SA; Aitken M; Donath SM; Gaff CL; Winship IM; Delatycki MB; Skene LL; McClaren BJ; Paul JL; Halliday JL
    BMC Med Genet; 2014 Mar; 15():33. PubMed ID: 24628824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of a randomised controlled trial of a complex genetic counselling intervention to improve family communication.
    Hodgson J; Metcalfe S; Gaff C; Donath S; Delatycki MB; Winship I; Skene L; Aitken M; Halliday J
    Eur J Hum Genet; 2016 Mar; 24(3):356-60. PubMed ID: 26130486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A tailored approach towards informing relatives at risk of inherited cardiac conditions: study protocol for a randomised controlled trial.
    van den Heuvel LM; Hoedemaekers YM; Baas AF; van Tintelen JP; Smets EMA; Christiaans I
    BMJ Open; 2019 Jul; 9(7):e025660. PubMed ID: 31289060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct letters to relatives at risk of hereditary cancer-study protocol for a multi-center randomized controlled trial of healthcare-assisted versus family-mediated risk disclosure at Swedish cancer genetics clinics (DIRECT-study).
    Hawranek C; Ehrencrona H; Öfverholm A; Hellquist BN; Rosén A
    Trials; 2023 Dec; 24(1):810. PubMed ID: 38105176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating a custom-designed aid to improve communication of genetic results in families with hypertrophic cardiomyopathy: study protocol for a randomised controlled trial.
    Burns C; Yeates L; Semsarian C; Ingles J
    BMJ Open; 2019 Feb; 9(1):e026627. PubMed ID: 30782759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Informing relatives about their hereditary or familial cancer risk: study protocol for a randomized controlled trial.
    de Geus E; Aalfs CM; Verdam MG; de Haes HC; Smets EM
    Trials; 2014 Mar; 15():86. PubMed ID: 24649895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving the referral process for familial breast cancer genetic counselling: findings of three randomised controlled trials of two interventions.
    Wilson BJ; Torrance N; Mollison J; Wordsworth S; Gray JR; Haites NE; Grant A; Campbell MK; Miedyzbrodzka Z; Clarke A; Watson MS; Douglas A
    Health Technol Assess; 2005 Feb; 9(3):iii-iv, 1-126. PubMed ID: 15694064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Personalising genetic counselling (POETIC) trial: Protocol for a hybrid type II effectiveness-implementation randomised clinical trial of a patient screening tool to improve patient empowerment after cancer genetic counselling.
    Forrest LE; Tutty E; De Silva AP; Petelin L; Ruscigno A; Purvis R; Monohan K; Kentwell M; Sexton A; Stafford L; James PA
    Trials; 2023 Nov; 24(1):712. PubMed ID: 37941026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proband-mediated interventions to increase disclosure of genetic risk in families with a BRCA or Lynch syndrome condition: a systematic review.
    Young AL; Imran A; Spoelma MJ; Williams R; Tucker KM; Halliday J; Forrest LE; Wakefield CE; Butow PN
    Eur J Hum Genet; 2023 Jan; 31(1):18-34. PubMed ID: 36253533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A tailored approach to informing relatives at risk of inherited cardiac conditions: results of a randomised controlled trial.
    van den Heuvel LM; Hoedemaekers YM; Baas AF; Baars MJH; van Tintelen JP; Smets EMA; Christiaans I
    Eur J Hum Genet; 2022 Feb; 30(2):203-210. PubMed ID: 34815540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased genetic counseling support improves communication of genetic information in families.
    Forrest LE; Burke J; Bacic S; Amor DJ
    Genet Med; 2008 Mar; 10(3):167-72. PubMed ID: 18344705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetics Adviser: a protocol for a mixed-methods randomised controlled trial evaluating a digital platform for genetics service delivery.
    Shickh S; Hirjikaka D; Clausen M; Kodida R; Mighton C; Reble E; Sam J; Panchal S; Aronson M; Graham T; Armel SR; Glogowski E; Elser C; Eisen A; Carroll JC; Shuman C; Seto E; Baxter NN; Scheer A; Shastri-Estrada S; Feldman G; Thorpe KE; Schrader KA; Lerner-Ellis J; Kim RH; Faghfoury H; Bombard Y
    BMJ Open; 2022 Apr; 12(4):e060899. PubMed ID: 35487723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The AMBER care bundle for hospital inpatients with uncertain recovery nearing the end of life: the ImproveCare feasibility cluster RCT.
    Koffman J; Yorganci E; Murtagh F; Yi D; Gao W; Barclay S; Pickles A; Higginson I; Johnson H; Wilson R; Bailey S; Ewart C; Evans C
    Health Technol Assess; 2019 Oct; 23(55):1-150. PubMed ID: 31594555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Supporting disclosure of genetic information to family members: professional practice and timelines in cancer genetics.
    Derbez B; de Pauw A; Stoppa-Lyonnet D; de Montgolfier S
    Fam Cancer; 2017 Jul; 16(3):447-457. PubMed ID: 28293859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of genetic services with and without genetic registers: knowledge, adjustment, and attitudes about genetic counselling among probands referred to three genetic clinics.
    Wright C; Kerzin-Storrar L; Williamson PR; Fryer A; Njindou A; Quarrell O; Donnai D; Craufurd D
    J Med Genet; 2002 Dec; 39(12):e84. PubMed ID: 12471222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct contact in inviting high-risk members of hereditary colon cancer families to genetic counselling and DNA testing.
    Aktan-Collan K; Haukkala A; Pylvänäinen K; Järvinen HJ; Aaltonen LA; Peltomäki P; Rantanen E; Kääriäinen H; Mecklin JP
    J Med Genet; 2007 Nov; 44(11):732-8. PubMed ID: 17630403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How to support cancer genetics counselees in informing at-risk relatives? Lessons from a randomized controlled trial.
    Eijzenga W; de Geus E; Aalfs CM; Menko FH; Sijmons RH; de Haes HCJM; Smets EMA
    Patient Educ Couns; 2018 Sep; 101(9):1611-1619. PubMed ID: 29789176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.